AVEO Oncology
AVEO
#6582
Rank
A$0.79 B
Marketcap
$22.78
Share price
0.00%
Change (1 day)
161.58%
Change (1 year)

Revenue for AVEO Oncology (AVEO)

Revenue in 2022 (TTM): A$0.13 Billion

According to AVEO Oncology 's latest financial reports the company's current revenue (TTM ) is A$0.14 Billion. In 2021 the company made a revenue of A$58.33 Million an increase over the revenue in the year 2020 that were of A$7.82 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AVEO Oncology from 2009 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) A$0.13 B132.69%
2021 A$58.33 M645.29%
2020 A$7.82 M-80.97%
2019 A$41.12 M435.65%
2018 A$7.67 M-20.91%
2017 A$9.7 M178.24%
2016 A$3.48 M-86.64%
2015 A$26.11 M17.92%
2014 A$22.14 M1427.73%
2013 A$1.44 M-92.19%
2012 A$18.55 M-88.46%
2011 A$0.16 B265.49%
2010 A$43.98 M90.72%
2009 A$23.06 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
A$14.68 B 10,154.56%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.02 B 14,581.14%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$72.03 B 50,192.09%๐Ÿ‡บ๐Ÿ‡ธ USA
A$62.05 B 43,224.57%๐Ÿ‡บ๐Ÿ‡ธ USA
A$49.40 B 34,393.58%๐Ÿ‡บ๐Ÿ‡ธ USA